All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Peptide Cost Guide: Monthly Budget

Peptide cost per month for BPC-157, TB-500, CJC/Ipamorelin, and more. Budget your peptide protocol with real pricing and stack costs.

By FormBlends Editorial Research|Source reviewed by FormBlends Medical Team||

Source Reviewed

Written by FormBlends Editorial Research · Checked against primary sources by FormBlends Medical Team

Peptide Cost Guide: Monthly Budget custom 2026 header image for GLP-1 Weight Loss
Custom header image for Peptide Cost Guide: Monthly Budget, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: Peptide Cost Guide: Monthly Budget

Peptide cost per month for BPC-157, TB-500, CJC/Ipamorelin, and more. Budget your peptide protocol with real pricing and stack costs.

Short answer

Peptide cost per month for BPC-157, TB-500, CJC/Ipamorelin, and more. Budget your peptide protocol with real pricing and stack costs.

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, retatrutide, peptide evidence quality

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

See your GLP-1 options in about 2 minutes. Free and private. See my options →

Peptide cost per month for BPC-157, TB-500, CJC/Ipamorelin, and more. Budget your peptide protocol with real pricing and stack costs.

Medically reviewed by Dr. James Park, MD, PhD (Chief Science Officer, Johns Hopkins-trained, 28 published papers

Planning a peptide protocol means understanding the real monthly costs. This peptide cost per month budget resource covers the important information you need to make informed decisions. Peptide cost per month varies widely depending on which peptides you use, your dosing schedule, and where you source them. This budget guide covers the most popular peptides with realistic pricing so you can plan your protocol without surprises.

Key Takeaways: - Individual Peptide Monthly Costs - Stack Costs: Popular Combinations - Hidden Costs and Total Budget Planning - Learn how to reduce your peptide costs

Peptide therapy has become more accessible through licensed telehealth providers and compounding pharmacies. But the market can be confusing. Some providers charge for the peptide only, while others bundle consultations, supplies, and shipping. This guide breaks it all down.

Individual Peptide Monthly Costs

Here are the most commonly prescribed peptides with typical monthly cost ranges through licensed providers and 503A compounding pharmacies. Prices reflect the medication cost and may not include consultation or shipping fees.

BPC-157 is one of the most popular and affordable peptides. Monthly costs typically range from $30 to $80 depending on dosing and vial size. A standard protocol of 250mcg twice daily using a 5mg vial lasts about 10 days, meaning you need roughly 3 vials per month. Some providers offer multi-vial pricing that reduces the per-vial cost.

TB-500 costs approximately $40 to $100 per month. During the loading phase (higher doses for the first 4 to 6 weeks), costs are at the higher end. Maintenance dosing (lower frequency after loading) brings monthly costs down significantly. A typical maintenance protocol uses one 5mg vial per month or less.

CJC-1295 (no DAC) runs about $40 to $80 per month at standard dosing. Combined with ipamorelin, the total for the pair is typically $60 to $120 per month. These peptides are often prescribed together as a growth hormone releasing protocol.

Ipamorelin costs $30 to $70 per month as a standalone. Since it's almost always prescribed alongside CJC-1295, budget for the combined cost. Some providers offer the combination in a single vial, which can reduce costs.

"The key to successful GLP-1 therapy is setting realistic expectations and supporting patients through the titration phase. The side effects are manageable for most people, but they need to know what to expect.") Dr. Caroline Apovian, MD, Harvard Medical School

GHK-Cu typically costs $30 to $60 per month. It's used at lower doses than many other peptides, which keeps monthly costs reasonable. It can be administered as subcutaneous injections or topically depending on the indication.

All peptides should be prescribed by a licensed provider for specific clinical indications. Never purchase research-grade peptides for human use. For detailed information on specific peptides, read our BPC-157 complete guide.


Free Download: Cost Comparison Spreadsheet A printable budget planner for peptide protocols including individual and stack pricing at common dose levels. Fill in your specific protocol and see your monthly and quarterly costs. Get yours free (we'll email it to you instantly.

[Download Now]


Many peptide protocols involve using multiple peptides together. Here is what popular stacks cost per month.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Peptide Cost Guide: Monthly Budget

BPC-157 + TB-500 ("Wolverine Stack") is the most popular combination for tissue repair and recovery. Monthly cost ranges from $70 to $180 depending on dosing phase. The loading phase (first 4 to 6 weeks) is more expensive due to higher TB-500 doses. Maintenance drops to $50 to $100 per month. Read our complete Wolverine Stack guide for detailed protocol information.

Patient Perspective: "My insurance denied Wegovy twice. My provider helped me file a peer-to-peer review appeal with supporting documentation from my labs and BMI history. Third time was approved. Don't give up after the first denial.") Brian C., 45, FormBlends patient (name changed for privacy)

CJC-1295 + Ipamorelin is the standard growth hormone releasing stack. Monthly cost runs $60 to $120. Some providers offer this combination pre-mixed in a single vial, which can lower costs and simplify reconstitution. This stack is typically run for 3 to 6 month cycles.

BPC-157 + GHK-Cu combines healing and skin rejuvenation support. Monthly cost is approximately $60 to $140. This is a lighter stack financially and is often used as a maintenance protocol after a more intensive initial phase.

Full recovery stack (BPC-157 + TB-500 + CJC/Ipa) represents the most thorough (and expensive) common protocol. Monthly cost during the loading phase can reach $130 to $300. Maintenance phase drops to $100 to $200. This stack is typically run for specific recovery goals rather than indefinitely.

GLP-1 + peptide combinations are increasingly common. If you're on semaglutide or tirzepatide and adding a peptide protocol, budget the GLP-1 cost separately. Combined monthly costs for GLP-1 plus a peptide like BPC-157 range from $180 to $480 depending on your specific medications and provider.

When budgeting for stacks, also factor in supplies. Syringes, bacteriostatic water, alcohol swabs, and sharps containers add $10 to $20 per month. Use our reconstitution calculator to plan exact quantities.

Hidden Costs and Total Budget Planning

The peptide itself is the biggest cost, but it isn't the only one. Here is everything to include in your monthly budget.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →

Provider consultation fees range from $0 (included with medication purchase at some providers) to $100 or more per visit. Some telehealth providers charge a monthly membership fee that covers unlimited messaging and periodic check-ins. Others charge per visit.

Lab work may be recommended before starting certain peptide protocols and periodically during treatment. Blood panels for IGF-1, inflammatory markers, or metabolic panels can cost $50 to $300 depending on your insurance and lab provider. Your provider will advise on frequency.

Supplies are relatively inexpensive but add up. A month's worth of insulin syringes, bacteriostatic water, and alcohol swabs typically costs $10 to $20. Sharps disposal containers cost a few dollars and last months.

Shipping varies by provider. Some include shipping in the medication price. Others charge $5 to $15 per shipment. Cold chain shipping (required for reconstituted peptides) may cost more.

Protocol duration affects your total investment. Most peptide protocols run 8 to 16 weeks for a full cycle. Multiply your monthly cost by the protocol duration for your total expected spend. A 12-week BPC-157 protocol at $60 per month totals $180. A 12-week full recovery stack at $200 per month totals $600.

HSA/FSA eligibility may apply. Peptides prescribed by a licensed provider for a diagnosed medical condition may qualify as eligible HSA or FSA expenses. This saves you 20 to 35 percent in tax savings. Consult your tax advisor. Learn more in our HSA and FSA guide.

How to Reduce Your Peptide Costs

Smart strategies can lower your monthly peptide spending without compromising your protocol.

Buy in bulk when possible. Many compounding pharmacies and providers offer discounted pricing for multi-vial orders. If your provider prescribes a 12-week protocol, ordering all vials upfront can save 10 to 20 percent versus buying one at a time.

Improve your dosing schedule. Work with your provider to find the minimum effective dose. Higher doses don't always mean better results. Some patients achieve excellent outcomes at doses lower than the maximum recommended.

Use multi-dose vials efficiently. Larger vials (like 10mg instead of 5mg) often have a lower cost per milligram. If your protocol supports it, larger vials provide better value. Just ensure you use the vial within its stability window (4 to 6 weeks after reconstitution).

Time your protocols. If you're running a recovery stack for a specific injury or goal, plan a defined protocol length rather than open-ended use. This prevents unnecessary spending after you have achieved your objective.

Compare providers. Pricing varies across telehealth platforms and compounding pharmacies. Compare total costs including medication, consultations, shipping, and supplies. FormBlends pricing is transparent so you know exactly what you'll pay.

Frequently Asked Questions

What is the cheapest peptide protocol?

BPC-157 as a standalone peptide is typically the most affordable option at $30 to $80 per month. It's also one of the most widely prescribed and researched peptides. Your provider will recommend the protocol that matches your clinical needs, not just the cheapest option.

Do insurance plans cover peptide therapy?

Most insurance plans don't cover compounded peptides. But peptides prescribed for specific diagnosed medical conditions may qualify as HSA or FSA eligible expenses. The out-of-pocket cost for peptides through licensed providers remains affordable for many patients.

How long do I need to budget for a typical peptide protocol?

Most peptide protocols run 8 to 16 weeks for a full cycle. Some conditions require longer protocols. Your provider will outline the expected duration based on your specific goals and response to treatment. Budget for the full recommended protocol length.

Are cheaper peptide sources safe?

Be cautious with very low-priced peptide sources. Research-grade peptides sold without a prescription aren't intended for human use and may not meet pharmaceutical quality standards. Always use peptides prescribed by a licensed provider and prepared by a licensed compounding pharmacy.

Can I combine GLP-1 treatment with peptides?

Yes, many patients use GLP-1 medications alongside peptide protocols. The medications work through different mechanisms and can complement each other. Your provider will evaluate your complete treatment plan for safety and appropriateness. Budget for both medications separately.

Your Personalized Plan Is Waiting

No two patients are the same, and your protocol shouldn't be either. FormBlends providers create customized treatment plans based on your health profile, goals, and preferences.

Get Your Personalized Plan →


Medical References

  1. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397(10278):971-984. [PubMed | ClinicalTrials.gov | DOI]
  2. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3). JAMA. 2021;325(14):1403-1413. [PubMed | ClinicalTrials.gov | DOI]
  3. Garvey WT, Batterham RL, Bhatt DL, et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28(10):2083-2091. [PubMed | ClinicalTrials.gov | DOI]
  4. Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2). Lancet. 2023;402(10402):613-626. [PubMed | ClinicalTrials.gov | DOI]
  5. Wadden TA, Chao AM, Engel S, et al. Tirzepatide with intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3). Nat Med. 2024. [PubMed | ClinicalTrials.gov | DOI]
  6. Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4). JAMA. 2024;331(1):38-48. [PubMed | ClinicalTrials.gov | DOI]

Sources &. References

  1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
  2. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
  3. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
  4. Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
  5. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563
  6. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. Doi:10.1056/NEJMoa2206038
  7. Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2[4] (Garvey et al., Lancet, 2023)). Lancet. 2023;402(10402):613-626. Doi:10.1016/S0140-6736(23)01200-X
  8. Wadden TA, Chao AM, Engel S, et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3[5] (Wadden et al., Nat Med, 2023)). Nat Med. 2023. Doi:10.1038/s41591-023-02597-w
  9. Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4[6] (Aronne et al., JAMA, 2024)). JAMA. 2024;331(1):38-48. Doi:10.1001/jama.2023.24945
  10. Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024;391:1193-1205. Doi:10.1056/NEJMoa2404881
  11. Centers for Disease Control and Prevention. Multistate Outbreak of Fungal Meningitis and Other Infections, United States, 2012. MMWR. 2012;61(41):839-842.
  12. U.S. Food and Drug Administration. Drug Quality and Security Act (DQSA). Public Law 113-54. November 27, 2013.

Nothing in this article should be construed as medical advice. The information provided is educational only. Always consult with your healthcare provider before beginning, modifying, or discontinuing any medication or treatment. FormBlends connects patients with licensed providers for individualized care.

Last updated: 2026-03-24

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →

Research Snapshot

Pricing guide
Page type
Pricing guide
FormBlends review
Last reviewed
2026-04-01
FormBlends review
FormBlends official source
Official source
Retatrutide evidence source
Official source
Semaglutide evidence source
Official source
Tirzepatide evidence source
Official source
Wegovy evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Peptide Cost Guide: Monthly Budget, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Systematic reviewGLP-1 class evidence2025

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition

Supports body-composition, lean-mass, and metabolic-risk context.

PubMed

ReviewBPC-157 evidence2025

Multifunctionality and Possible Medical Application of the BPC 157 Peptide

Used to frame BPC-157 as an investigational peptide with mixed preclinical and limited human evidence.

PubMed

ReviewBPC-157 evidence2019

Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing

Supports cautious tissue-repair context without presenting BPC-157 as an approved therapy.

PubMed

Systematic reviewBPC-157 evidence2025

Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review

Useful for injury-recovery pages where human evidence limits need to be explicit.

PubMed

ReviewThymosin beta-4 evidence2007

beta-Thymosins

Background source for thymosin biology and tissue-repair mechanisms.

PubMed

ReviewThymosin beta-4 evidence2018

Thymosin beta 4 and the eye: the journey from bench to bedside

Shows how thymosin beta-4 evidence differs by route, tissue, and clinical application.

PubMed

ReviewThymosin beta-4 evidence2023

Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies

Used only for broad regenerative-medicine context, not as proof of consumer outcomes.

PubMed

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Direct answer

Peptide Cost Guide: Monthly Budget research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

Peptide cost per month for BPC-157, TB-500, CJC/Ipamorelin, and more. Budget your peptide protocol with real pricing and stack costs. Before you use "Peptide Cost Guide: Monthly Budget" to make a real decision, separate the headline answer from the details that could change it. The page connects cost planning and access checks with BPC-157, TB-500, cost and coverage, inside a GLP-1 treatment guide where medication choice, dosing, side effects, monitoring, and insurance rules can change the decision. Because this article has 7 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. Bring anything that changes dosing, pharmacy choice, cost, or safety to a licensed clinician.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Verify total monthly cost, refill timing, dose escalation pricing, and what is included before paying.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Peptide Cost Guide

For this glp-1 weight loss page, the 2026 refresh focuses on semaglutide, tirzepatide, retatrutide, BPC-157, cash-pay pricing, safety signals so the article stays close to the question behind "Peptide Cost Guide".

The useful details are the practical ones: what to verify, what changes risk or cost, and which details separate Peptide Cost Guide from nearby GLP-1, peptide, hormone, or provider-comparison searches.

Readers can use the added context to bring sharper questions to a licensed provider before making a treatment, cost, or care decision.

Peptide Cost Guide custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for Peptide Cost Guide, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering Peptide Cost Guide, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research. Claims are checked against primary regulatory, trial, label, and public-health sources where available. Reviewed by FormBlends Medical Team for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.